{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T18:05:15Z","timestamp":1764785115631,"version":"3.41.2"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T00:00:00Z","timestamp":1682640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Since 2009, a series of ambitious health system reforms have been launched in China, including the zero mark-up drug policy (ZMDP); the policy was intended to reduce substantial medicine expenses for patients by abolishing the 15% mark-up on drugs. This study aims to evaluate the impacts of ZMDP on medical expenditures from the perspective of disease burden disparities in western China.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>Two typical diseases including Type 2 diabetes mellitus (T2DM) in internal medicine and cholecystolithiasis (CS) in surgery were selected from medical records in a large tertiary level-A hospital in SC Province. The monthly average medical expenses of patients from May 2015 to August 2018 were extracted to construct an interrupted time series (ITS) model to evaluate the impact of policy implementation on the economic burden.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 5,764 cases were enrolled in our study. The medicine expenses for T2DM patients maintained a negative trend both before and after the intervention of ZMDP. It had declined by 74.3 CNY (<jats:italic>P<\/jats:italic> &amp;lt; 0.001) per month on average in the pre-policy period and subsequently dropped to 704.4 CNY (<jats:italic>P<\/jats:italic> = 0.028) immediately after the policy. The level change of hospitalization expenses was insignificant (<jats:italic>P<\/jats:italic> = 0.197), with a reduction of 677.7 CNY after the policy, while the post-policy long-term trend was significantly increased by 97.7 CNY (<jats:italic>P<\/jats:italic> = 0.035) per month contrasted with the pre-policy period. In addition, the anesthesia expenses of T2DM patients had a significant increase in the level under the impact of the policy. In comparison, the medicine expenses of CS patients significantly decreased by 1,014.2 CNY (<jats:italic>P<\/jats:italic> &amp;lt; 0.001) after the policy, while the total hospitalization expenses had no significant change in level and slope under the influence of ZMDP. Furthermore, the expenses of surgery and anesthesia for CS patients significantly increased by 320.9 CNY and 331.4 CNY immediately after the policy intervention.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our study indicated that the ZMDP has been an effective intervention to reduce the excessive medicine expenses for both researched medical and surgical diseases, but failed to show any long-term advantage. Moreover, the policy has no significant impact on relieving the overall hospitalization burden for either condition.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpubh.2023.1079655","type":"journal-article","created":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T14:07:23Z","timestamp":1682690843000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Impacts of the zero mark-up policy on hospitalization expenses of T2DM and cholecystolithiasis inpatients in SC province, western China: an interrupted time series analysis"],"prefix":"10.3389","volume":"11","author":[{"given":"Xirui","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinchuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fangqing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongju","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hengbo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongqin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XiaoHong","family":"Gan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enwu","family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,4,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e0143130","DOI":"10.1371\/journal.pone.0143130","article-title":"Impact of China's public hospital reform on healthcare expenditures and utilization: a case study in ZJ Province","volume":"10","author":"Zhang","year":"2015","journal-title":"PLoS ONE."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e70836","DOI":"10.1371\/journal.pone.0070836","article-title":"Measuring access to medicines: a survey of prices, availability and affordability in Shaanxi province of China","volume":"8","author":"Jiang","year":"2013","journal-title":"PLoS ONE."},{"key":"B3","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.healthpol.2009.07.009","article-title":"Pharmaceutical reforms: implications through comparisons of Korea and Japan","volume":"93","author":"Jeong","year":"2009","journal-title":"Health Policy."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1016\/S0140-6736(09)60753-4","article-title":"Launch of the health-care reform plan in China","volume":"373","author":"Chen","year":"2009","journal-title":"Lancet."},{"key":"B5","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1186\/s12913-020-05378-0","article-title":"Impacts of the zero mark-up drug policy on hospitalization expenses of COPD inpatients in Sichuan province, western China: an interrupted time series analysis","volume":"20","author":"Wang","year":"2020","journal-title":"BMC Health Serv Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1146\/annurev-publhealth-031816-044247","article-title":"China's health reform update","volume":"38","author":"Liu","year":"2017","journal-title":"Annu Rev Public Health."},{"key":"B7","doi-asserted-by":"publisher","first-page":"l2349","DOI":"10.1136\/bmj.l2349","article-title":"What can we learn from China's health system reform?","volume":"365","author":"Meng","year":"2019","journal-title":"BMJ."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e918","DOI":"10.1002\/hpm.2562","article-title":"A retrospective and prospective assessment of the zero-markup drug reform in China from the perspective of policy diffusion","volume":"33","author":"Deng","year":"2018","journal-title":"Int J Health Plann Manage."},{"key":"B9","doi-asserted-by":"publisher","first-page":"664","DOI":"10.2471\/BLT.12.102178","article-title":"Factors affecting catastrophic health expenditure and impoverishment from medical expenses in China: policy implications of universal health insurance","volume":"90","author":"Li","year":"2012","journal-title":"Bull World Health Organ."},{"key":"B10","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.jhealeco.2011.05.009","article-title":"Patient knowledge and antibiotic abuse: evidence from an audit study in China","volume":"30","author":"Currie","year":"2011","journal-title":"J Health Econ."},{"key":"B11","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1007\/s10728-009-0127-y","article-title":"Serve the people: understanding ideology and professional ethics of medicine in China","volume":"18","author":"Yang","year":"2010","journal-title":"Health Care Anal."},{"key":"B12","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1377\/hlthaff.27.2.460","article-title":"The Chinese health system at a crossroads","volume":"27","author":"Yip","year":"2008","journal-title":"Health Aff (Millwood)."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/S0140-6736(10)60063-3","article-title":"Realignment of incentives for health-care providers in China","volume":"375","author":"Yip","year":"2010","journal-title":"Lancet."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.ncl.2016.06.003","article-title":"Health care in China","volume":"34","author":"Younger","year":"2016","journal-title":"Neurol Clin."},{"key":"B15","unstructured":""},{"key":"B16","unstructured":""},{"key":"B17","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12992-019-0486-6","article-title":"The development and reform of public health in China from 1949 to 2019","volume":"15","author":"Wang","year":"2019","journal-title":"Global Health."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e029646","DOI":"10.1136\/bmjopen-2019-029646","article-title":"Impact of China's healthcare price reforms on traditional Chinese medicine public hospitals in Beijing: an interrupted time-series study","volume":"9","author":"Zhu","year":"2019","journal-title":"BMJ Open."},{"key":"B19","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1186\/s12913-021-06414-3","article-title":"Impact of China's zero mark-up drug policy on drug cost of NCDs' outpatients: an interrupted time series analysis","volume":"21","author":"Du","year":"2021","journal-title":"BMC Health Serv Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1377\/hlthaff.2014.1114","article-title":"Intended and unintended consequences of China's zero markup drug policy","volume":"34","author":"Yi","year":"2015","journal-title":"Health Aff (Millwood)."},{"key":"B21","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1210\/er.2015-1137","article-title":"Sex and gender differences in risk, pathophysiology and complications of type 2 diabetes mellitus","volume":"37","author":"Kautzky-Willer","year":"2016","journal-title":"Endocr Rev."},{"key":"B22","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.ecl.2020.05.012","article-title":"Diabetes insipidus: an update","volume":"49","author":"Refardt","year":"2020","journal-title":"Endocrinol Metab Clin North Am."},{"key":"B23","doi-asserted-by":"publisher","first-page":"ITC1","DOI":"10.7326\/AITC201503030","article-title":"In the clinic. Type 2 diabetes","volume":"162","author":"Vijan","year":"2015","journal-title":"Ann Intern Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"107843","DOI":"10.1016\/j.diabres.2019.107843","article-title":"Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9 edition","volume":"157","author":"Saeedi","year":"2019","journal-title":"Diabetes Res Clin Pract."},{"key":"B25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1177\/2047487319881021","article-title":"The global epidemics of diabetes in the 21st century: current situation and perspectives","volume":"26","author":"Standl","year":"2019","journal-title":"Eur J Prev Cardiol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"108078","DOI":"10.1016\/j.diabres.2020.108078","article-title":"Diabetes and global ageing among 65-99-year-old adults: Findings from the International Diabetes Federation Diabetes Atlas, 9 edition","volume":"162","author":"Sinclair","year":"2020","journal-title":"Diabetes Res Clin Pract."},{"key":"B27","doi-asserted-by":"publisher","first-page":"108072","DOI":"10.1016\/j.diabres.2020.108072","article-title":"Global and regional estimates and projections of diabetes-related health expenditure: results from the International Diabetes Federation Diabetes Atlas, 9th edition","volume":"162","author":"Williams","year":"2020","journal-title":"Diabetes Res Clin Pract."},{"key":"B28","doi-asserted-by":"publisher","first-page":"16024","DOI":"10.1038\/nrdp.2016.24","article-title":"Gallstones","volume":"2","author":"Lammert","year":"2016","journal-title":"Nat Rev Dis Primers."},{"key":"B29","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3238\/arztebl.2020.0148","article-title":"The treatment of gallstone disease","volume":"117","author":"Gutt","year":"2020","journal-title":"Dtsch Arztebl Int."},{"key":"B30","unstructured":""},{"volume-title":"Sichuan Statistics Bureau. Sichuan Statistical Yearbook 2021","year":"","key":"B31"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e64733","DOI":"10.1371\/journal.pone.0064733","article-title":"Impact of STROBE statement publication on quality of observational study reporting: interrupted time series versus before-after analysis","volume":"8","author":"Bastuji-Garin","year":"2013","journal-title":"PLoS ONE."},{"key":"B33","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1093\/jac\/dkg459","article-title":"Outcomes of an intervention to improve hospital antibiotic prescribing: interrupted time series with segmented regression analysis","volume":"52","author":"Ansari","year":"2003","journal-title":"J Antimicrob Chemother."},{"key":"B34","first-page":"348","article-title":"Interrupted time series regression for the evaluation of public health interventions: a tutorial","volume":"46","author":"Bernal","year":"2017","journal-title":"Int J Epidemiol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/jcpt.13551","article-title":"Impact of the national centralized drug procurement policy (4 + 7 policy) on the drug expenditures of patients treated in outpatient and emergency departments in a large tertiary level-A hospital in China: A single centre, interrupted time series","volume":"47","author":"Lan","year":"2022","journal-title":"J Clin Pharm Ther."},{"key":"B36","doi-asserted-by":"publisher","first-page":"956823","DOI":"10.3389\/fpubh.2022.956823","article-title":"The impact of national centralized drug procurement on health expenditures for lung cancer inpatients: a difference-in-differences analysis in a large tertiary hospital in China","volume":"10","author":"Zhang","year":"2022","journal-title":"Front Public Health."},{"key":"B37","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/ijerph17249415","article-title":"The impacts of national centralized drug procurement policy on drug utilization and drug expenditures: the case of Shenzhen, China","volume":"17","author":"Chen","year":"2020","journal-title":"Int J Environ Res Public Health."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1186\/s12889-021-11882-7","article-title":"Influence of Chinese National Centralized Drug Procurement on the price of policy-related drugs: an interrupted time series analysis","volume":"21","author":"Wang","year":"2021","journal-title":"BMC Public Health."},{"key":"B39","doi-asserted-by":"publisher","first-page":"38","DOI":"10.2105\/AJPH.71.1.38","article-title":"Analysis of interrupted time series mortality trends: an example to evaluate regionalized perinatal care","volume":"71","author":"Gillings","year":"1981","journal-title":"Am J Public Health."},{"key":"B40","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1046\/j.1365-2710.2002.00430.x","article-title":"Segmented regression analysis of interrupted time series studies in medication use research","volume":"27","author":"Wagner","year":"2002","journal-title":"J Clin Pharm Ther."},{"key":"B41","doi-asserted-by":"publisher","first-page":"e0201349","DOI":"10.1371\/journal.pone.0201349","article-title":"Access to medicines for acute illness and antibiotic use in residents: A medicines household survey in Sichuan Province, western China","volume":"13","author":"Deng","year":"2018","journal-title":"PLoS ONE."},{"key":"B42","doi-asserted-by":"publisher","first-page":"e002086","DOI":"10.1136\/bmjgh-2019-002086","article-title":"Towards universal health coverage: lessons from 10 years of healthcare reform in China","volume":"5","author":"Tao","year":"2020","journal-title":"BMJ Glob Health."}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2023.1079655\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T14:07:30Z","timestamp":1682690850000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2023.1079655\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,28]]},"references-count":42,"alternative-id":["10.3389\/fpubh.2023.1079655"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2023.1079655","relation":{},"ISSN":["2296-2565"],"issn-type":[{"type":"electronic","value":"2296-2565"}],"subject":[],"published":{"date-parts":[[2023,4,28]]},"article-number":"1079655"}}